{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:17:25Z","timestamp":1783131445074,"version":"3.54.6"},"reference-count":181,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020450","name":"Soochow University","doi-asserted-by":"publisher","award":["XKTJ-XK202403"],"award-info":[{"award-number":["XKTJ-XK202403"]}],"id":[{"id":"10.13039\/501100020450","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018916","name":"Suzhou Municipal Health Commission","doi-asserted-by":"publisher","award":["GSWS2023041"],"award-info":[{"award-number":["GSWS2023041"]}],"id":[{"id":"10.13039\/100018916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018916","name":"Suzhou Municipal Health Commission","doi-asserted-by":"publisher","award":["Qngg2023008"],"award-info":[{"award-number":["Qngg2023008"]}],"id":[{"id":"10.13039\/100018916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473327"],"award-info":[{"award-number":["82473327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302385"],"award-info":[{"award-number":["82302385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014358","name":"Second Affiliated Hospital of Soochow University","doi-asserted-by":"publisher","award":["SDFEYBS2218"],"award-info":[{"award-number":["SDFEYBS2218"]}],"id":[{"id":"10.13039\/501100014358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20241921"],"award-info":[{"award-number":["BK20241921"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013094","name":"Science and Technology Planning Social Development Project of Zhenjiang City","doi-asserted-by":"publisher","award":["SH2023055"],"award-info":[{"award-number":["SH2023055"]}],"id":[{"id":"10.13039\/501100013094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jare.2026.05.017","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:29:32Z","timestamp":1778761772000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From barrier invasion to niche formation: mechanisms and therapies in breast cancer brain metastases"],"prefix":"10.1016","author":[{"given":"Huan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingqi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1639-1005","authenticated-orcid":false,"given":"Yizheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2026.05.017_b0005","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries n.d. DOI: 10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"key":"10.1016\/j.jare.2026.05.017_b0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","volume":"5","author":"Achrol","year":"2019","journal-title":"Brain metastases Nat Rev Dis Primer"},{"key":"10.1016\/j.jare.2026.05.017_b0015","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41416-019-0619-y","article-title":"Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort","volume":"121","author":"Darlix","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40478-025-01983-4","article-title":"Biological profile of breast cancer brain metastasis","volume":"13","author":"Liu","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jare.2026.05.017_b0025","first-page":"1","article-title":"New insights into the correlations between circulating tumor cells and target organ metastasis","volume":"8","author":"Zhan","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2026.05.017_b0030","doi-asserted-by":"crossref","first-page":"12034","DOI":"10.3390\/ijms241512034","article-title":"Navigating the Blood\u2013Brain Barrier: challenges and Therapeutic strategies in Breast Cancer Brain Metastases","volume":"24","author":"Terceiro","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2026.05.017_b0035","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41563-023-01716-9","article-title":"Cell volume expansion and local contractility drive collective invasion of the basement membrane in breast cancer","volume":"23","author":"Chang","year":"2024","journal-title":"Nat Mater"},{"key":"10.1016\/j.jare.2026.05.017_b0040","article-title":"Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers","volume":"181","author":"Yuan","year":"2024","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"10.1016\/j.jare.2026.05.017_b0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12935-025-03973-x","article-title":"Breast neoplasm epithelial-mesenchymal transition and cytokines: a systematic review","volume":"25","author":"Chen","year":"2025","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jare.2026.05.017_b0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12964-024-01957-4","article-title":"The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors","volume":"22","author":"Liaghat","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jare.2026.05.017_b0055","doi-asserted-by":"crossref","unstructured":"Zhou S, Hong M, Zhao D, Li W, Yuan X, Wang Y, et al. Reprogramming the Tumor Immune Microenvironment with ICAM-1-Targeted Antibody\u2012Drug Conjugates and B7-H3-CD3 Bispecific Antibodies. Adv Sci n.d.;n\/a:2415577. DOI: 10.1002\/advs.202415577.","DOI":"10.1002\/advs.202415577"},{"key":"10.1016\/j.jare.2026.05.017_b0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix Metalloproteinases: regulators of the Tumor Microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jare.2026.05.017_b0065","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3390\/molecules30061380","article-title":"Targeting the CXCR4\/CXCL12 Axis in Cancer Therapy: Analysis of recent advances in the Development of potential Anticancer Agents","volume":"30","author":"Smaldone","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.jare.2026.05.017_b0070","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.molonc.2014.06.006","article-title":"HER2 mediated de novo production of TGF\u03b2 leads to SNAIL driven epithelial-to-mesenchymal transition and metastasis of breast cancer","volume":"8","author":"Gupta","year":"2014","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0075","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1158\/1535-7163.MCT-19-0461","article-title":"Identification of ALDH1A3 as a viable therapeutic target in breast cancer metastasis-initiating cells","volume":"19","author":"Yamashita","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jare.2026.05.017_b0080","first-page":"48","article-title":"ELK3-CYFIP2 axis-mediated actin remodeling modulatesmetastasis and natural killer cell responses in triple-negative breast cancer","volume":"44","author":"Choi","year":"2025","journal-title":"J Exp Clin Cancer Res CR"},{"key":"10.1016\/j.jare.2026.05.017_b0085","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2147\/OTT.S293685","article-title":"Understanding patterns of brain metastasis in triple-negative breast cancer and exploring potential therapeutic targets","volume":"14","author":"Lv","year":"2021","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.jare.2026.05.017_b0090","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt0504","article-title":"EYA3 regulation of NF-\u03baB and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasis","volume":"11","author":"Rosenbaum","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.jare.2026.05.017_b0095","article-title":"Clinical significance and heterogeneity of circulating tumor cells and clusters in breast cancer subtypes","volume":"13","author":"Hao","year":"2025","journal-title":"PeerJ"},{"key":"10.1016\/j.jare.2026.05.017_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020376","article-title":"Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer","volume":"12","author":"Papadaki","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jare.2026.05.017_b0105","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202001134","article-title":"Cancer cells educate natural killer cells to a metastasis-promoting cell state","volume":"219","author":"Chan","year":"2020","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jare.2026.05.017_b0110","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.bpj.2025.05.018","article-title":"Microtubule polymerization generates microtentacles important in circulating tumor cell invasion","volume":"124","author":"Kainka","year":"2025","journal-title":"Biophys J"},{"key":"10.1016\/j.jare.2026.05.017_b0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41523-017-0008-8","article-title":"Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12","volume":"3","author":"Chung","year":"2017","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0120","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.29155","article-title":"Metastasis blood test by flow cytometry: In vivo cancer spheroids and the role of hypoxia","volume":"136","author":"Denes","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1631\/jzus.B2200269","article-title":"aggravate tumor progression through HIF-1\u03b1-SERPINE1 signaling in glioblastoma","volume":"24","author":"Hypoxia-induced","year":"2023","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.jare.2026.05.017_b0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41568-023-00639-6","article-title":"The dynamic role of platelets in cancer progression and their therapeutic implications","volume":"24","author":"Li","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0135","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/s41388-024-03075-4","article-title":"Distinguishing high-metastasis-potential circulating tumor cells through fluidic shear stress in a bloodstream-like microfluidic circulatory system","volume":"43","author":"Li","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2026.05.017_b0140","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12032-025-02787-1","article-title":"Targeting platelet-tumor cell interactions: a novel approach to cancer therapy","volume":"42","author":"Rab","year":"2025","journal-title":"Med Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0145","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","article-title":"Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jare.2026.05.017_b0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10555-020-09881-y","article-title":"Molecular and cellular mechanisms underlying brain metastasis of breast cancer","volume":"39","author":"Hosonaga","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jare.2026.05.017_b0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","article-title":"Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets","volume":"60","author":"Liang","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jare.2026.05.017_b0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12885-016-2366-2","article-title":"The effect of soluble E-selectin on tumor progression and metastasis","volume":"16","author":"Kang","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0170","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1158\/0008-5472.CAN-22-3964","article-title":"Active Remodeling of Capillary Endothelium via Cancer Cell-Derived MMP9 Promotes Metastatic Brain Colonization","volume":"83","author":"Karreman","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.05.017_b0175","article-title":"Immunotherapy biomarkers in brain metastases: Insights into tumor microenvironment dynamics","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2026.05.017_b0180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/brainsci15030279","article-title":"Molecular motors in blood-brain barrier maintenance by astrocytes","volume":"15","author":"Sobral","year":"2025","journal-title":"Brain Sci"},{"key":"10.1016\/j.jare.2026.05.017_b0185","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.it.2024.09.005","article-title":"Sensory nerves unlock the TOLL-7 gate for cancer spread","volume":"45","author":"Malireddi","year":"2024","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jare.2026.05.017_b0190","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1021\/acsnano.9b04397","article-title":"Tumor-Derived Extracellular Vesicles Breach the Intact Blood\u2013Brain Barrier via Transcytosis","volume":"13","author":"Morad","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jare.2026.05.017_b0195","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","article-title":"Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis","volume":"25","author":"Zhou","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jare.2026.05.017_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120738","article-title":"Metabolic and epigenetic reprogramming in circulating tumor cells: advances in liquid biopsy and cancer management","volume":"580","author":"Duggina","year":"2026","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jare.2026.05.017_b0205","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1038\/s41388-019-0893-4","article-title":"FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis","volume":"38","author":"Cordero","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2026.05.017_b0210","doi-asserted-by":"crossref","unstructured":"Mondal J, Nylund P, Malgulwar PB, Johnson WE, Huse JT. Synaptic transmission promotes brain metastatic outgrowth in breast cancer. JCI Insight n.d.;10:e193119. DOI: 10.1172\/jci.insight.193119.","DOI":"10.1172\/jci.insight.193119"},{"key":"10.1016\/j.jare.2026.05.017_b0215","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41422-024-00946-z","article-title":"Multiple cancer cell types release LIF and Gal3 to hijack neural signals","volume":"34","author":"Xu","year":"2024","journal-title":"Cell Res"},{"key":"10.1016\/j.jare.2026.05.017_b0220","article-title":"The role of kinase inhibitors in cancer neuroscience: Mechanisms, therapeutic potential, and future directions","author":"Vlasiou","year":"2025","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.jare.2026.05.017_b0225","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41388-019-0959-3","article-title":"TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment","volume":"39","author":"Sirkisoon","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2026.05.017_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-024-01509-5","article-title":"Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition","author":"Yuzhalin","year":"2024","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jare.2026.05.017_b0235","article-title":"The Single\u2010Cell Landscape of Intratumoral Heterogeneity and the Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer","volume":"10","author":"Zou","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.jare.2026.05.017_b0240","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47-SIRP\u03b1 Immune Checkpoint","volume":"52","author":"Logtenberg","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jare.2026.05.017_b0245","article-title":"Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jare.2026.05.017_b0250","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ccell.2020.10.004","article-title":"YTHDF3 Induces the translation of m6A-enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis","volume":"38","author":"Chang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jare.2026.05.017_b0255","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41556-024-01446-3","article-title":"Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3","volume":"26","author":"Seehawer","year":"2024","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jare.2026.05.017_b0260","doi-asserted-by":"crossref","first-page":"12654","DOI":"10.3390\/ijms222312654","article-title":"Blood\u2013Brain Barrier in Brain Tumors: Biology and Clinical Relevance","volume":"22","author":"Mo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2026.05.017_b0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/pharmaceutics13010015","article-title":"Focused Ultrasound and Microbubbles-Mediated Drug delivery to Brain Tumor","volume":"13","author":"Wu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jare.2026.05.017_b0270","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.ccell.2024.08.015","article-title":"Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain","volume":"42","author":"Gan","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jare.2026.05.017_b0275","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41551-018-0334-7","article-title":"Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium","volume":"3","author":"Seano","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jare.2026.05.017_b0280","doi-asserted-by":"crossref","DOI":"10.1126\/science.adh5548","article-title":"Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis","volume":"384","author":"Whiteley","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jare.2026.05.017_b0285","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-019-1576-6","article-title":"Synaptic proximity enables NMDAR signalling to promote brain metastasis","volume":"573","author":"Zeng","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jare.2026.05.017_b0290","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-020-1999-0","article-title":"MAFG-driven astrocytes promote CNS inflammation","volume":"578","author":"Wheeler","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jare.2026.05.017_b0295","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.3681","article-title":"Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation","volume":"20","author":"Mayo","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2026.05.017_b0300","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","article-title":"Disease-associated astrocytes in Alzheimer\u2019s disease and aging","volume":"23","author":"Habib","year":"2020","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jare.2026.05.017_b0305","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41591-018-0044-4","article-title":"STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis","volume":"24","author":"Priego","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2026.05.017_b0310","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","article-title":"Serpins promote cancer cell survival and vascular co-option in brain metastasis","volume":"156","author":"Valiente","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jare.2026.05.017_b0315","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/2159-8290.CD-21-0976","article-title":"Tumor immune microenvironment of brain metastases: Towards unlocking anti-tumor immunity","volume":"12","author":"Strickland","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jare.2026.05.017_b0320","doi-asserted-by":"crossref","DOI":"10.1002\/bit.70144","article-title":"Astrocytes protect brain metastatic breast cancer cells from chemotherapy through CX43 dependent STAT1 signaling in co-culture spheroids","author":"Yakati","year":"2026","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.jare.2026.05.017_b0325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13058-017-0844-3","article-title":"Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases","volume":"19","author":"Choy","year":"2017","journal-title":"Breast Cancer Res BCR"},{"key":"10.1016\/j.jare.2026.05.017_b0330","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrneurol.2014.207","article-title":"Microglial and macrophage polarization-new prospects for brain repair","volume":"11","author":"Hu","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jare.2026.05.017_b0335","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11481-009-9164-4","article-title":"Heterogeneity of microglial activation in the innate immune response in the brain","volume":"4","author":"Colton","year":"2009","journal-title":"J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol"},{"key":"10.1016\/j.jare.2026.05.017_b0340","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5405104","article-title":"The Polarization States of Microglia in TBI: a New Paradigm for Pharmacological intervention","volume":"2017","author":"Xu","year":"2017","journal-title":"Neural Plast"},{"key":"10.1016\/j.jare.2026.05.017_b0345","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb1817","article-title":"T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection","volume":"5","author":"Moseman","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jare.2026.05.017_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.814999","article-title":"Microglial activation modulated by P2X4R in ischemia and repercussions in alzheimer\u2019s disease","volume":"13","author":"Castillo","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.jare.2026.05.017_b0355","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11060-020-03483-y","article-title":"Immune suppression in gliomas","volume":"151","author":"Grabowski","year":"2021","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jare.2026.05.017_b0360","unstructured":"Chen P. Mechanism and therapeutic potential of macrophage regulation in glioblastoma n.d."},{"key":"10.1016\/j.jare.2026.05.017_b0365","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/neuonc\/noac136","article-title":"A comprehensive profiling of the immune microenvironment of breast cancer brain metastases","volume":"24","author":"Griguolo","year":"2022","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0370","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1158\/0008-5472.CAN-18-1102","article-title":"Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis","volume":"78","author":"Xing","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.05.017_b0375","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/brain\/awae347","article-title":"CCL2 blockade combined with PD-1\/P-selectin immunomodulators impedes breast cancer brain metastasis","volume":"148","author":"Israeli Dangoor","year":"2025","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.jare.2026.05.017_b0380","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the Microenvironmental Landscape in Brain Tumors reveals Disease-specific Alterations of Immune Cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jare.2026.05.017_b0385","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/cas.13101","article-title":"Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients","volume":"107","author":"Ogiya","year":"2016","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jare.2026.05.017_b0390","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/annonc\/mdy399","article-title":"Immunological differences between primary and metastatic breast cancer","volume":"29","author":"Szekely","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13058-018-1003-1","article-title":"Immune characterization of breast cancer metastases: prognostic implications","volume":"20","author":"Dieci","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jare.2026.05.017_b0400","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/neuonc\/noy084","article-title":"Immunotherapy in CNS cancers: the role of immune cell trafficking","volume":"21","author":"Ratnam","year":"2019","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0405","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cell.2020.06.026","article-title":"Microglia require CD4 T Cells to complete the Fetal-to-Adult transition","volume":"182","author":"Pasciuto","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jare.2026.05.017_b0410","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1016\/j.immuni.2021.09.016","article-title":"Early developing B cells undergo negative selection by central nervous system-specific antigens in the meninges","volume":"54","author":"Wang","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jare.2026.05.017_b0415","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1215\/15228517-2008-104","article-title":"Regulatory T cells and the PD-L1\/PD-1 pathway mediate immune suppression in malignant human brain tumors","volume":"11","author":"Jacobs","year":"2009","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0420","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/cncr.34084","article-title":"Regulatory T cells: their role in triple-negative breast cancer progression and metastasis","volume":"128","author":"Malla","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0425","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.molmed.2021.12.008","article-title":"NK Cells in the Brain: Implications for Brain Tumor Development and Therapy","volume":"28","author":"Balatsoukas","year":"2022","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jare.2026.05.017_b0430","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/biom11071058","article-title":"Oligodendrocytes and Microglia: Key Players in Myelin Development","volume":"11","author":"Kalafatakis","year":"2021","journal-title":"Damage and Repair Biomolecules"},{"key":"10.1016\/j.jare.2026.05.017_b0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228534","article-title":"Management of Brain and Leptomeningeal Metastases from Breast Cancer","volume":"21","author":"Pellerino","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2026.05.017_b0440","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.6004\/jnccn.2020.0052","article-title":"Central nervous System Cancers, Version 3.2020, NCCN Clinical Practice guidelines in Oncology","volume":"18","author":"Nabors","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jare.2026.05.017_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106934","article-title":"Ferritin nanoconjugates guide trastuzumab brain delivery to promote an antitumor response in murine HER2+breast cancer brain metastasis","volume":"196","author":"Sevieri","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jare.2026.05.017_b0450","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41571-023-00849-9","article-title":"Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives","volume":"21","author":"Marra","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0455","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/neuonc\/noae123","article-title":"Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases","volume":"26","author":"Bartsch","year":"2024","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0460","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.SABCS24-P5-05-01","article-title":"Abstract P5-05-01: real world treatment patterns and outcomes in her-2 positive metastatic breast cancer patients with brain metastases","volume":"31","author":"Mestres-Villanueva","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.05.017_b0465","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s11523-016-0429-6","article-title":"Long-Term Survivor with Intrathecal and Intravenous Trastuzumab Treatment in Metastatic Breast Cancer","volume":"11","author":"Pluchart","year":"2016","journal-title":"Target Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0470","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/cncr.30616","article-title":"Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies","volume":"123","author":"Miller","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0475","doi-asserted-by":"crossref","DOI":"10.1002\/onco.13830","article-title":"Efficacy of Neratinib Plus Capecitabine in the Subgroup of patients with Central nervous System Involvement from the NALA Trial","volume":"26","author":"Hurvitz","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.jare.2026.05.017_b0480","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJMoa1914609","article-title":"Tucatinib, Trastuzumab, and Capecitabine for HER2-positive Metastatic Breast Cancer","volume":"382","author":"Murthy","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2026.05.017_b0485","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.annonc.2021.12.005","article-title":"Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis","volume":"33","author":"Curigliano","year":"2022","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0490","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1200\/JCO.20.00775","article-title":"Intracranial Efficacy and Survival with Tucatinib Plus Trastuzumab and Capecitabine for previously Treated HER2-positive Breast Cancer with Brain Metastases in the HER2CLIMB Trial","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0495","doi-asserted-by":"crossref","first-page":"403","DOI":"10.4143\/crt.2014.165","article-title":"Effective Treatment of Solitary Pituitary Metastasis with Panhypopituitarism in HER2-positive Breast Cancer by Lapatinib","volume":"48","author":"Park","year":"2016","journal-title":"Cancer Res Treat Off J Korean Cancer Assoc"},{"key":"10.1016\/j.jare.2026.05.017_b0500","doi-asserted-by":"crossref","unstructured":"Parsai S, Miller JA, Juloori A, Chao ST, Kotecha R, Mohammadi AM, et al. Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases 2019. DOI: 10.3171\/2018.10.JNS182340.","DOI":"10.3171\/2018.10.JNS182340"},{"key":"10.1016\/j.jare.2026.05.017_b0505","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1108772","article-title":"Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: a meta-analysis","volume":"14","author":"Xun","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2026.05.017_b0510","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13058-020-01372-w","article-title":"Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases","volume":"22","author":"Leone","year":"2020","journal-title":"Breast Cancer Res BCR"},{"key":"10.1016\/j.jare.2026.05.017_b0515","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3816\/CBC.2009.n.021","article-title":"Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series","volume":"9","author":"Labidi","year":"2009","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0520","first-page":"325","article-title":"Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases from Breast Cancer: a Randomized Clinical Trial. JAMA","volume":"10","author":"Chen","year":"2024","journal-title":"Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0525","article-title":"Significant response of low-dose apatinib monotherapy in brain metastases of triple-negative breast cancer: a case report","volume":"98","author":"Li","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jare.2026.05.017_b0530","doi-asserted-by":"crossref","unstructured":"Cj, Lord, A A. PARP inhibitors: Synthetic lethality in the clinic. Science 2017;355. DOI: 10.1126\/science.aam7344.","DOI":"10.1126\/science.aam7344"},{"key":"10.1016\/j.jare.2026.05.017_b0535","doi-asserted-by":"crossref","unstructured":"M D, L R, Z S, M K, Km T, C N, et al. Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors. Ann Oncol Off J Eur Soc Med Oncol 2018;29. DOI: 10.1093\/annonc\/mdy216.","DOI":"10.1093\/annonc\/mdy216"},{"key":"10.1016\/j.jare.2026.05.017_b0540","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13058-021-01409-8","article-title":"Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+\/HER2- metastatic breast cancer in US real-world clinical practice","volume":"23","author":"DeMichele","year":"2021","journal-title":"Breast Cancer Res BCR"},{"key":"10.1016\/j.jare.2026.05.017_b0545","doi-asserted-by":"crossref","unstructured":"I R, Mk von W, C S, J T. Ribociclib in Breast Cancer Brain Metastases: A Case Report. Breast Care Basel Switz 2020;15. DOI: 10.1159\/000504405.","DOI":"10.1159\/000504405"},{"key":"10.1016\/j.jare.2026.05.017_b0550","article-title":"Abstract PS7-07: Elacestrant plus abemaciclib (abema) combination in patients (pts) with estrogen receptor-positive (ER+), HER2-negative (HER2-) advanced or metastatic breast cancer (mBC)","volume":"31","author":"Rugo","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.05.017_b0555","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41586-020-2969-2","article-title":"A metastasis map of human cancer cell lines","volume":"588","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jare.2026.05.017_b0560","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.19.00368","article-title":"Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-negative Breast Cancer: the PAKT Trial","volume":"38","author":"Schmid","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0565","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/neuonc\/noz105","article-title":"Targeting the PI3K\/Akt\/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases","volume":"21","author":"Ippen","year":"2019","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0570","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3892\/ol.2022.13313","article-title":"Significance of combined TGF-\u03b21 and survivin expression on the prognosis of patients with triple-negative breast cancer","volume":"23","author":"Liu","year":"2022","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jare.2026.05.017_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144216","article-title":"Discovery of a transforming growth factor-\u03b21 inhibitory peptide, Charis 1000 to enhance the therapeutic efficacy of paclitaxel in triple-negative breast cancer","volume":"314","author":"Song","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jare.2026.05.017_b0580","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005543","article-title":"Anti-TGF-\u03b2\/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer","volume":"10","author":"Yi","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0585","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004122","article-title":"Colocalized targeting of TGF-\u03b2 and PD-L1 by bintrafusp alfa elicits distinct antitumor responses","volume":"10","author":"Lan","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101405","article-title":"Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response","volume":"20","author":"Rupp","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0595","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"IMpassion130 Trial investigators. Atezolizumab and Nab-Paclitaxel in Advanced Triple-negative Breast Cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2026.05.017_b0600","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus Chemotherapy in Advanced Triple-negative Breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2026.05.017_b0605","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.annonc.2022.07.1940","article-title":"Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response","volume":"33","author":"Loibl","year":"2022","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0610","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jamaoncol.2018.4224","article-title":"Long-term Clinical Outcomes and Biomarker analyses of Atezolizumab Therapy for patients with Metastatic Triple-negative Breast Cancer: a phase 1 Study","volume":"5","author":"Emens","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0615","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13058-016-0702-8","article-title":"Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1\/PD-L axis","volume":"18","author":"Duchnowska","year":"2016","journal-title":"Breast Cancer Res BCR"},{"key":"10.1016\/j.jare.2026.05.017_b0620","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1158\/1078-0432.CCR-15-1849","article-title":"Reversing T-cell Dysfunction and Exhaustion in Cancer","volume":"22","author":"Zarour","year":"2016","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.jare.2026.05.017_b0625","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00262-017-2089-5","article-title":"Targeting and suppression of HER3-positive breast cancer by T lymphocytes expressing a heregulin chimeric antigen receptor","volume":"67","author":"Zuo","year":"2017","journal-title":"Cancer Immunol Immunother CII"},{"key":"10.1016\/j.jare.2026.05.017_b0630","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1135","article-title":"EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo","volume":"9","author":"Xia","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.jare.2026.05.017_b0635","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10549-022-06783-1","article-title":"EGFR as a potent CAR T target in triple negative breast cancer brain metastases","volume":"197","author":"Subham","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jare.2026.05.017_b0640","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1158\/1078-0432.CCR-17-2041","article-title":"Regional delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain","volume":"24","author":"Priceman","year":"2018","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.jare.2026.05.017_b0645","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/2326-6066.CIR-17-0189","article-title":"Safety and efficacy of intratumoral injections of chimeric antigen receptor (CAR) T cells in metastatic breast cancer","volume":"5","author":"Tchou","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jare.2026.05.017_b0650","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jconrel.2023.10.007","article-title":"Engineering CAR-NK cell derived exosome disguised nano-bombs for enhanced HER2 positive breast cancer brain metastasis therapy","volume":"363","author":"Tao","year":"2023","journal-title":"J Control Release Off J Control Release Soc"},{"key":"10.1016\/j.jare.2026.05.017_b0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-018-0066-6","article-title":"A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma\/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release","volume":"4","author":"Xu","year":"2018","journal-title":"Cell Discov"},{"key":"10.1016\/j.jare.2026.05.017_b0660","doi-asserted-by":"crossref","first-page":"13504","DOI":"10.3390\/ijms252413504","article-title":"Genetically engineered T cells and recombinant antibodies to target intracellular neoantigens: current status and future directions","volume":"25","author":"Waaga-Gasser","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2026.05.017_b0665","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-24-0168","article-title":"TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer","author":"Kortleve","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jare.2026.05.017_b0670","first-page":"5924","article-title":"PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer","volume":"15","author":"Li","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jare.2026.05.017_b0675","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-022-00257-2","article-title":"Research progress on dendritic cell vaccines in cancer immunotherapy","volume":"11","author":"Yu","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0680","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41523-025-00742-x","article-title":"A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer","volume":"11","author":"Soliman","year":"2025","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.jare.2026.05.017_b0685","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.SABCS24-PS3-03","article-title":"Abstract PS3-03: Vaccination with MUC-1-targeting tecemotide improves Survival of patients receiving neo-adjuvant chemotherapy for early breast cancer: results from the prospective Randomized ABCSG 34 Trial","volume":"31","author":"Singer","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.05.017_b0690","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2096363","article-title":"Trial watch: Dendritic cell (DC)-based immunotherapy for cancer","volume":"11","author":"Laureano","year":"2022","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jare.2026.05.017_b0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115427","article-title":"The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis","volume":"44","author":"Wischnewski","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2026.05.017_b0700","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1360\/TB-2023-0802","article-title":"Nanotechnology-based drug delivery strategies for cancer therapy","volume":"68","author":"Xu","year":"2023","journal-title":"Chin Sci Bull"},{"key":"10.1016\/j.jare.2026.05.017_b0705","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2016.12.019","article-title":"Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer","volume":"246","author":"He","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.jare.2026.05.017_b0710","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1021\/nn501069c","article-title":"A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood-brain barrier targeting brain metastases of breast cancer","volume":"8","author":"Li","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jare.2026.05.017_b0715","article-title":"Autocatalytic delivery of Brain Tumor-targeting, Size-shrinkable Nanoparticles for Treatment of Breast Cancer Brain Metastases","volume":"30","author":"Zhang","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.jare.2026.05.017_b0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123262","article-title":"Manganese-based virus-mimicking nanomedicine with triple immunomodulatory functions inhibits breast cancer brain metastasis","volume":"320","author":"Zhao","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jare.2026.05.017_b0725","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/cam4.5021","article-title":"Breast cancer brain metastasis: current evidence and future directions","volume":"12","author":"Sun","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.jare.2026.05.017_b0730","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/nano9010105","article-title":"Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies","volume":"9","author":"Caffery","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jare.2026.05.017_b0735","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nri2971","article-title":"Illuminating viral infections in the nervous system","volume":"11","author":"McGavern","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jare.2026.05.017_b0740","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/v16030442","article-title":"Natural adeno-associated virus serotypes and engineered adeno-associated virus capsid variants: Tropism differences and mechanistic insights","volume":"16","author":"Lopez-Gordo","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.jare.2026.05.017_b0745","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0391-24.2024","article-title":"Comparative analysis of six adeno-associated viral vector serotypes in mouse inferior colliculus and cerebellum","volume":"11","author":"Witteveen","year":"2024","journal-title":"eNeuro"},{"key":"10.1016\/j.jare.2026.05.017_b0750","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17091167","article-title":"A preliminary study on the accuracy of MRI-guided thalamic infusion of AAV2-GFP and biodistribution analysis using cryo-fluorescence tomography in nonhuman primates","volume":"17","author":"Salegio","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jare.2026.05.017_b0755","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adr2531","article-title":"An AAV variant selected through NHP screens robustly transduces the brain and drives secreted protein expression in NHPs and mice","volume":"17","author":"Tecedor","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jare.2026.05.017_b0760","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41434-024-00466-w","article-title":"Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles","volume":"31","author":"Bunuales","year":"2024","journal-title":"Gene Ther"},{"key":"10.1016\/j.jare.2026.05.017_b0765","doi-asserted-by":"crossref","DOI":"10.3390\/ctn9030032","article-title":"Implications of AAV serotypes in neurological disorders: current clinical applications and challenges","volume":"9","author":"Sharma","year":"2025","journal-title":"Clin Transl Neurosci"},{"key":"10.1016\/j.jare.2026.05.017_b0770","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41551-022-00938-7","article-title":"Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood\u2013brain barrier in rodents and primates","volume":"6","author":"Yao","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jare.2026.05.017_b0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-025-05170-2","article-title":"Emerging trends in cell-based therapies: contemporary advances and ethical considerations in translational neurosurgical oncology","volume":"175","author":"Abikenari","year":"2025","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jare.2026.05.017_b0780","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/14737175.2025.2490543","article-title":"Advances in stem cell-based therapeutic transfers for glioblastoma treatment","volume":"25","author":"Bardhan","year":"2025","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jare.2026.05.017_b0785","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12951-025-03181-9","article-title":"Intranasal delivery of engineered extracellular vesicles promotes neurofunctional recovery in traumatic brain injury","volume":"23","author":"Li","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.jare.2026.05.017_b0790","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1158\/1078-0432.CCR-16-1518","article-title":"Neural Stem Cell\u2013Based Anticancer Gene Therapy: a First-in-Human Study in Recurrent High-Grade Glioma patients","volume":"23","author":"Portnow","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.05.017_b0795","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S1470-2045(21)00245-X","article-title":"Neural Stem Cell delivery of an Oncolytic Adenovirus in newly DiagnosedMalignant Glioma: a First-in-Human, phase 1 Clinical Trial","volume":"22","author":"Fares","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0800","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noad179.0312","article-title":"CTNI-30. MESENCHYMAL STEM CELL (MSC11FCD) BASED THERAPY ELICITED a FAVORABLE RESPONSE WITH EFFICIENT 5-FU CONVERSION IN PATIENTS WITH RECURRENT GLIOBLASTOMA: AN OPEN LABEL, PHASE I\/IIA TRIAL","volume":"25","author":"Lim","year":"2023","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0805","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2026.05.017_b0810","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biomaterials.2018.06.029","article-title":"NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma invitro and in vivo","volume":"178","author":"Jia","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jare.2026.05.017_b0815","article-title":"The Antitumor effect of Gene-Engineered Exosomes in the Treatment of Brain Metastasis of Breast Cancer. Front","volume":"10","author":"Liu","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.jare.2026.05.017_b0820","doi-asserted-by":"crossref","first-page":"63","DOI":"10.20517\/evcna.2022.04","article-title":"Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy","volume":"3","author":"Liu","year":"2022","journal-title":"Extracell Vesicles Circ Nucleic Acids"},{"key":"10.1016\/j.jare.2026.05.017_b0825","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2023.10.027","article-title":"Engineered bacterial extracellular vesicles for central nervous system diseases","volume":"364","author":"Ji","year":"2023","journal-title":"J Control Release Off J Control Release Soc"},{"key":"10.1016\/j.jare.2026.05.017_b0830","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202418053","article-title":"Engineered bacterial outer membrane vesicles-based doxorubicin and CD47-siRNA co-delivery nanoplatform overcomes immune resistance to potentiate the immunotherapy of glioblastoma","volume":"37","author":"You","year":"2025","journal-title":"Adv Mater"},{"key":"10.1016\/j.jare.2026.05.017_b0835","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: Physiology and strategies for drug delivery","volume":"165\u2013166","author":"Pandit","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jare.2026.05.017_b0840","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.4103\/1673-5374.284992","article-title":"Targeting cannabidiol to specific areas of the brain: an ultrasound-based strategy","volume":"15","author":"Branca","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.jare.2026.05.017_b0845","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3171\/2017.8.JNS17790","article-title":"Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound","volume":"130","author":"Stavarache","year":"2019","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jare.2026.05.017_b0850","doi-asserted-by":"crossref","first-page":"9255","DOI":"10.1038\/s41598-019-45577-2","article-title":"Ultrasound-mediated blood-brain barrier opening enhances delivery of therapeutically relevant formats of a tau-specific antibody","volume":"9","author":"Janowicz","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2026.05.017_b0855","article-title":"Noninvasive focal transgene delivery with viral neuronal tracers in the marmoset monkey","volume":"4","author":"Parks","year":"2024","journal-title":"Cell Rep Methods"},{"key":"10.1016\/j.jare.2026.05.017_b0860","doi-asserted-by":"crossref","first-page":"19402","DOI":"10.1038\/s41598-019-55294-5","article-title":"Focused ultrasound enhanced intranasal delivery of brain derived neurotrophic factor produces neurorestorative effects in a Parkinson\u2019s disease mouse model","volume":"9","author":"Ji","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2026.05.017_b0865","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/1061186X.2019.1656724","article-title":"Low intensity ultrasound targeted microbubble destruction assists MSCs delivery and improves neural function in brain ischaemic rats","volume":"28","author":"Cui","year":"2020","journal-title":"J Drug Target"},{"key":"10.1016\/j.jare.2026.05.017_b0870","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6086","article-title":"Clinical trial of blood-brain barrier disruption by pulsed ultrasound","volume":"8","author":"Carpentier","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jare.2026.05.017_b0875","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41598-018-36340-0","article-title":"Blood-Brain Barrier opening in Primary Brain Tumors with Non-invasive MR-Guided Focused Ultrasound: a Clinical Safety and Feasibility Study","volume":"9","author":"Mainprize","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2026.05.017_b0880","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1807105115","article-title":"Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood\u2013tumor barrier disruption","volume":"115","author":"Arvanitis","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2026.05.017_b0885","article-title":"Neuronavigation-guided focused ultrasound for transcranial blood-brain barrier opening and immunostimulation in brain tumors","volume":"7","author":"Chen","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jare.2026.05.017_b0890","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","article-title":"Repeated blood\u2013brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial","volume":"15","author":"Carpentier","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.05.017_b0895","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11060-023-04517-x","article-title":"Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study","volume":"165","author":"Chen","year":"2023","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jare.2026.05.017_b0900","doi-asserted-by":"crossref","unstructured":"Pujade-Lauraine E, Brown J, Barnicle A, Wessen J, Lao-Sirieix P, Criscione SW, et al. Homologous recombination repair gene mutations to predict olaparib plus bevacizumab efficacy in the first-line ovarian cancer PAOLA-1\/ENGOT-ov25 trial. JCO Precis Oncol 2023:e2200258. DOI: 10.1200\/PO.22.00258.","DOI":"10.1200\/PO.22.00258"},{"key":"10.1016\/j.jare.2026.05.017_b0905","article-title":"Impact of multidisciplinary team on the pattern of care for brain metastasis from breast cancer. Front","volume":"13","author":"Xu","year":"2023","journal-title":"Oncol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226003930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226003930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:31:55Z","timestamp":1783128715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123226003930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":181,"alternative-id":["S2090123226003930"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2026.05.017","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From barrier invasion to niche formation: mechanisms and therapies in breast cancer brain metastases","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2026.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}